Point72 Asset Management
LYEL icon

Point72 Asset Management’s Lyell Immunopharma LYEL Stock Holding History

Point72 Asset Management’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-340
Closed -$15.2K – 1526
2024
Q1 		$15.2K Buy
+340
New +$15.2K ﹤0.01% 1378
2021
Q3 		– Sell
-1,250
Closed -$406K – 1085
2021
Q2 		$406K Buy
+1,250
New +$406K ﹤0.01% 820